• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.33% Nasdaq Down 0.30%

    Intercept Pharmaceuticals, Inc. (ICPT)

    -NasdaqGS
    240.89 Up 3.66(1.54%) 2:42PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:237.23
    Open:236.13
    Bid:239.84 x 200
    Ask:240.42 x 200
    1y Target Est:409.00
    Beta:-8.97
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:236.00 - 240.89
    52wk Range:128.50 - 349.08
    Volume:153,567
    Avg Vol (3m):491,768
    Market Cap:5.80B
    P/E (ttm):N/A
    EPS (ttm):-3.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ICPT

    Comparison

    Symbol% ChgMkt Cap
    ICPTUp 1.54%5.80B
    AZNUp 1.07%82.58B
    SLXPUp 0.09%11.10B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2,052.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-8.48
    Quarterly EPS Est (Jun-15) :-1.90
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-1.58

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback